 | • レポートコード：GIR201108123 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ロタウイルス感染症治療薬の世界市場を調査対象にし、ロタウイルス感染症治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（RV-3BB、RV-625、UMN-2001、ロタバック-5C、その他）、用途別分析（クリニック、病院、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Beijing Minhai Biotechnology Co Ltd、UMN Pharma Inc、Curevac AG、Bharat Biotech International Ltd、Serum Institute of India Ltd、Biological E Ltd、Nanotherapeutics Inc、Medicago Inc、Wuhan Institute of Biological Products Co Ltd ・メーカー別販売量、売上、市場シェア ・ロタウイルス感染症治療薬の地域別市場分析 ・ロタウイルス感染症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ロタウイルス感染症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ロタウイルス感染症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ロタウイルス感染症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ロタウイルス感染症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ロタウイルス感染症治療薬の種類別市場規模2015-2020：RV-3BB、RV-625、UMN-2001、ロタバック-5C、その他 ・ロタウイルス感染症治療薬の用途別市場規模2015-2020：クリニック、病院、その他 ・ロタウイルス感染症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Rotavirus Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Rotavirus Infections Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Rotavirus Infections Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rotavirus Infections Drug market has been segmented into
RV-3BB
RV-625
UMN-2001
Rotavac-5C
Others
By Application, Rotavirus Infections Drug has been segmented into:
Clinic
Hospital
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rotavirus Infections Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Rotavirus Infections Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rotavirus Infections Drug market.
The report offers in-depth assessment of the growth and other aspects of the Rotavirus Infections Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Rotavirus Infections Drug Market Share Analysis
Rotavirus Infections Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rotavirus Infections Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rotavirus Infections Drug sales, revenue and market share for each player covered in this report.
The major players covered in Rotavirus Infections Drug are:
Beijing Minhai Biotechnology Co Ltd
UMN Pharma Inc
Curevac AG
Bharat Biotech International Ltd
Serum Institute of India Ltd
Biological E Ltd
Nanotherapeutics Inc
Medicago Inc
Wuhan Institute of Biological Products Co Ltd
Among other players domestic and global, Rotavirus Infections Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rotavirus Infections Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rotavirus Infections Drug, with price, sales, revenue and global market share of Rotavirus Infections Drug in 2018 and 2019.
Chapter 3, the Rotavirus Infections Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rotavirus Infections Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Rotavirus Infections Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Rotavirus Infections Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Rotavirus Infections Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rotavirus Infections Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 RV-3BB
1.2.3 RV-625
1.2.4 UMN-2001
1.2.5 Rotavac-5C
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Rotavirus Infections Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Overview of Global Rotavirus Infections Drug Market
1.4.1 Global Rotavirus Infections Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Beijing Minhai Biotechnology Co Ltd
2.1.1 Beijing Minhai Biotechnology Co Ltd Details
2.1.2 Beijing Minhai Biotechnology Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Beijing Minhai Biotechnology Co Ltd SWOT Analysis
2.1.4 Beijing Minhai Biotechnology Co Ltd Product and Services
2.1.5 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 UMN Pharma Inc
2.2.1 UMN Pharma Inc Details
2.2.2 UMN Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 UMN Pharma Inc SWOT Analysis
2.2.4 UMN Pharma Inc Product and Services
2.2.5 UMN Pharma Inc Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Curevac AG
2.3.1 Curevac AG Details
2.3.2 Curevac AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Curevac AG SWOT Analysis
2.3.4 Curevac AG Product and Services
2.3.5 Curevac AG Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bharat Biotech International Ltd
2.4.1 Bharat Biotech International Ltd Details
2.4.2 Bharat Biotech International Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bharat Biotech International Ltd SWOT Analysis
2.4.4 Bharat Biotech International Ltd Product and Services
2.4.5 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Serum Institute of India Ltd
2.5.1 Serum Institute of India Ltd Details
2.5.2 Serum Institute of India Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Serum Institute of India Ltd SWOT Analysis
2.5.4 Serum Institute of India Ltd Product and Services
2.5.5 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biological E Ltd
2.6.1 Biological E Ltd Details
2.6.2 Biological E Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biological E Ltd SWOT Analysis
2.6.4 Biological E Ltd Product and Services
2.6.5 Biological E Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nanotherapeutics Inc
2.7.1 Nanotherapeutics Inc Details
2.7.2 Nanotherapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nanotherapeutics Inc SWOT Analysis
2.7.4 Nanotherapeutics Inc Product and Services
2.7.5 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Medicago Inc
2.8.1 Medicago Inc Details
2.8.2 Medicago Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Medicago Inc SWOT Analysis
2.8.4 Medicago Inc Product and Services
2.8.5 Medicago Inc Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Wuhan Institute of Biological Products Co Ltd
2.9.1 Wuhan Institute of Biological Products Co Ltd Details
2.9.2 Wuhan Institute of Biological Products Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Wuhan Institute of Biological Products Co Ltd SWOT Analysis
2.9.4 Wuhan Institute of Biological Products Co Ltd Product and Services
2.9.5 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Rotavirus Infections Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Rotavirus Infections Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Rotavirus Infections Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Rotavirus Infections Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Rotavirus Infections Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Rotavirus Infections Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Rotavirus Infections Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
4.3 Europe Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
4.5 South America Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Rotavirus Infections Drug Sales, Revenue and Market Share by Country
5.1.1 North America Rotavirus Infections Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Rotavirus Infections Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
5.3 Canada Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Rotavirus Infections Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Rotavirus Infections Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Rotavirus Infections Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
6.3 UK Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
6.4 France Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
6.5 Russia Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
6.6 Italy Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Rotavirus Infections Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Rotavirus Infections Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Rotavirus Infections Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
7.3 Japan Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
7.4 Korea Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
7.5 India Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
7.7 Australia Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Rotavirus Infections Drug Sales, Revenue and Market Share by Country
8.1.1 South America Rotavirus Infections Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Rotavirus Infections Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Rotavirus Infections Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Rotavirus Infections Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Rotavirus Infections Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Rotavirus Infections Drug Sales and Market Share by Type (2015-2020)
10.2 Global Rotavirus Infections Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Rotavirus Infections Drug Price by Type (2015-2020)
11 Global Rotavirus Infections Drug Market Segment by Application
11.1 Global Rotavirus Infections Drug Sales Market Share by Application (2015-2020)
11.2 Global Rotavirus Infections Drug Revenue Market Share by Application (2015-2020)
11.3 Global Rotavirus Infections Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Rotavirus Infections Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Rotavirus Infections Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Rotavirus Infections Drug Market Forecast (2021-2025)
12.2.2 Europe Rotavirus Infections Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Rotavirus Infections Drug Market Forecast (2021-2025)
12.2.4 South America Rotavirus Infections Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Rotavirus Infections Drug Market Forecast (2021-2025)
12.3 Rotavirus Infections Drug Market Forecast by Type (2021-2025)
12.3.1 Global Rotavirus Infections Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Rotavirus Infections Drug Market Share Forecast by Type (2021-2025)
12.4 Rotavirus Infections Drug Market Forecast by Application (2021-2025)
12.4.1 Global Rotavirus Infections Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Rotavirus Infections Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Rotavirus Infections Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rotavirus Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rotavirus Infections Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Beijing Minhai Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Major Business
Table 9. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 10. Beijing Minhai Biotechnology Co Ltd SWOT Analysis
Table 11. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product and Services
Table 12. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. UMN Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 14. UMN Pharma Inc Rotavirus Infections Drug Major Business
Table 15. UMN Pharma Inc Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 16. UMN Pharma Inc SWOT Analysis
Table 17. UMN Pharma Inc Rotavirus Infections Drug Product and Services
Table 18. UMN Pharma Inc Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Curevac AG Basic Information, Manufacturing Base and Competitors
Table 20. Curevac AG Rotavirus Infections Drug Major Business
Table 21. Curevac AG Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 22. Curevac AG SWOT Analysis
Table 23. Curevac AG Rotavirus Infections Drug Product and Services
Table 24. Curevac AG Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bharat Biotech International Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Bharat Biotech International Ltd Rotavirus Infections Drug Major Business
Table 27. Bharat Biotech International Ltd Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 28. Bharat Biotech International Ltd SWOT Analysis
Table 29. Bharat Biotech International Ltd Rotavirus Infections Drug Product and Services
Table 30. Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Serum Institute of India Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Serum Institute of India Ltd Rotavirus Infections Drug Major Business
Table 33. Serum Institute of India Ltd Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 34. Serum Institute of India Ltd SWOT Analysis
Table 35. Serum Institute of India Ltd Rotavirus Infections Drug Product and Services
Table 36. Serum Institute of India Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biological E Ltd Basic Information, Manufacturing Base and Competitors
Table 38. Biological E Ltd Rotavirus Infections Drug Major Business
Table 39. Biological E Ltd Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 40. Biological E Ltd SWOT Analysis
Table 41. Biological E Ltd Rotavirus Infections Drug Product and Services
Table 42. Biological E Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Nanotherapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. Nanotherapeutics Inc Rotavirus Infections Drug Major Business
Table 45. Nanotherapeutics Inc Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 46. Nanotherapeutics Inc SWOT Analysis
Table 47. Nanotherapeutics Inc Rotavirus Infections Drug Product and Services
Table 48. Nanotherapeutics Inc Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Medicago Inc Basic Information, Manufacturing Base and Competitors
Table 50. Medicago Inc Rotavirus Infections Drug Major Business
Table 51. Medicago Inc Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 52. Medicago Inc SWOT Analysis
Table 53. Medicago Inc Rotavirus Infections Drug Product and Services
Table 54. Medicago Inc Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Wuhan Institute of Biological Products Co Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Major Business
Table 57. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Total Revenue (USD Million) (2018-2019)
Table 58. Wuhan Institute of Biological Products Co Ltd SWOT Analysis
Table 59. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product and Services
Table 60. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Rotavirus Infections Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global Rotavirus Infections Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Rotavirus Infections Drug Sales by Regions (2015-2020) (K Pcs)
Table 64. Global Rotavirus Infections Drug Sales Market Share by Regions (2015-2020)
Table 65. Global Rotavirus Infections Drug Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Rotavirus Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 67. North America Rotavirus Infections Drug Sales Market Share by Countries (2015-2020)
Table 68. North America Rotavirus Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Rotavirus Infections Drug Revenue Market Share by Countries (2015-2020)
Table 70. Europe Rotavirus Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe Rotavirus Infections Drug Sales Market Share by Countries (2015-2020)
Table 72. Europe Rotavirus Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Rotavirus Infections Drug Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific Rotavirus Infections Drug Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Rotavirus Infections Drug Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Rotavirus Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 77. South America Rotavirus Infections Drug Sales Market Share by Countries (2015-2020)
Table 78. South America Rotavirus Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Rotavirus Infections Drug Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Rotavirus Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Rotavirus Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Rotavirus Infections Drug Revenue Market Share by Countries (2015-2020)
Table 84. Global Rotavirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 85. Global Rotavirus Infections Drug Sales Share by Type (2015-2020)
Table 86. Global Rotavirus Infections Drug Revenue by Type (2015-2020) (USD Million)
Table 87. Global Rotavirus Infections Drug Revenue Share by Type (2015-2020)
Table 88. Global Rotavirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 89. Global Rotavirus Infections Drug Sales Share by Application (2015-2020)
Table 90. Global Rotavirus Infections Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global Rotavirus Infections Drug Market Share Forecast by Regions (2021-2025)
Table 92. Global Rotavirus Infections Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global Rotavirus Infections Drug Market Share Forecast by Type (2021-2025)
Table 94. Global Rotavirus Infections Drug Sales Forecast by Application (2021-2025)
Table 95. Global Rotavirus Infections Drug Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Rotavirus Infections Drug Picture
Figure 2. Global Sales Market Share of Rotavirus Infections Drug by Type in 2019
Figure 3. RV-3BB Picture
Figure 4. RV-625 Picture
Figure 5. UMN-2001 Picture
Figure 6. Rotavac-5C Picture
Figure 7. Others Picture
Figure 8. Rotavirus Infections Drug Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Others Picture
Figure 12. Global Rotavirus Infections Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Rotavirus Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Rotavirus Infections Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Rotavirus Infections Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Rotavirus Infections Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Rotavirus Infections Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Rotavirus Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Rotavirus Infections Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Rotavirus Infections Drug Revenue Market Share by Regions in 2018
Figure 41. North America Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Rotavirus Infections Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Rotavirus Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Rotavirus Infections Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Rotavirus Infections Drug Sales Market Share by Countries in 2018
Figure 49. North America Rotavirus Infections Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Rotavirus Infections Drug Revenue Market Share by Countries in 2018
Figure 51. United States Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Rotavirus Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Rotavirus Infections Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Rotavirus Infections Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Rotavirus Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Rotavirus Infections Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Rotavirus Infections Drug Revenue Market Share by Regions 2019
Figure 65. China Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Rotavirus Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Rotavirus Infections Drug Sales Market Share by Countries in 2019
Figure 72. South America Rotavirus Infections Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Rotavirus Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Rotavirus Infections Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Rotavirus Infections Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Rotavirus Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Rotavirus Infections Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Rotavirus Infections Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Rotavirus Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Rotavirus Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Rotavirus Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Rotavirus Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Rotavirus Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
類鼻疽菌感染症治療薬の世界市場 2020年 Market Overview The global Burkholderia Pseudomallei Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bur…- ライノウイルス感染症治療薬の世界市場 2020年 Market Overview The global Rhinovirus Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rhinovirus Infecti…
- 髄膜炎菌感染症薬の世界市場 2020年 Market Overview The global Neisseria meningitidis Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neisse…
- インフルエンザAウイルス・H3N2サブタイプ感染症治療薬の世界市場 2020年 Market Overview The global Influenza A Virus, H3N2 Subtype Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- 人工関節感染症（PJI）治療の世界市場 2020年 Market Overview The global Prosthetic Joint Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prosthe…